{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:19:33Z","timestamp":1759011573959},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":730,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jcf.2012.06.006","type":"journal-article","created":{"date-parts":[[2012,10,7]],"date-time":"2012-10-07T09:15:14Z","timestamp":1349601314000},"page":"54-59","source":"Crossref","is-referenced-by-count":13,"title":["Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Ahmet Z.","family":"Uluer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Waltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie A.","family":"Kalish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summer","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn A.","family":"Ericson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcf.2012.06.006_bb0005","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/ajrccm.154.5.8912731","article-title":"Cystic fibrosis","volume":"154","author":"Davis","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5 Pt 1","key":"10.1016\/j.jcf.2012.06.006_bb0015","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1164\/ajrccm.160.5.9805046","article-title":"Burkholderia cepacia in cystic fibrosis. Variable disease course","volume":"160","author":"Frangolias","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2012.06.006_bb0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(84)80993-2","article-title":"Pseudomonas cepacia infection in cystic fibrosis: an emerging problem","volume":"104","author":"Isles","year":"1984","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2012.06.006_bb0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0022-3476(85)80511-4","article-title":"Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome","volume":"107","author":"Tablan","year":"1985","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.jcf.2012.06.006_bb0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1378\/chest.91.4.527","article-title":"Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes","volume":"91","author":"Tablan","year":"1987","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.jcf.2012.06.006_bb0035","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/thx.50.11.1194","article-title":"Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak","volume":"50","author":"Whiteford","year":"1995","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jcf.2012.06.006_bb0040","first-page":"212","article-title":"Burkholderia cepacia complex as human pathogens","volume":"35","author":"Lipuma","year":"2003","journal-title":"J Nematol"},{"issue":"4","key":"10.1016\/j.jcf.2012.06.006_bb0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.200503-344OC","article-title":"Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis","volume":"173","author":"Kalish","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2012.06.006_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"issue":"4615","key":"10.1016\/j.jcf.2012.06.006_bb0060","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1126\/science.6308769","article-title":"Abnormal ion permeation through cystic fibrosis respiratory epithelium","volume":"221","author":"Knowles","year":"1983","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jcf.2012.06.006_bb0065","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1172\/JCI112708","article-title":"Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation","volume":"78","author":"Boucher","year":"1986","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jcf.2012.06.006_bb0070","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1152\/jappl.1984.56.4.868","article-title":"Bioelectric properties and ion flow across excised human bronchi","volume":"56","author":"Knowles","year":"1984","journal-title":"J Appl Physiol"},{"issue":"25","key":"10.1016\/j.jcf.2012.06.006_bb0075","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJM198112173052502","article-title":"Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis","volume":"305","author":"Knowles","year":"1981","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcf.2012.06.006_bb0080","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/ajrccm\/141.3.605","article-title":"Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy","volume":"141","author":"App","year":"1990","journal-title":"Am Rev Respir Dis"},{"issue":"17","key":"10.1016\/j.jcf.2012.06.006_bb0085","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM199004263221704","article-title":"A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis","volume":"322","author":"Knowles","year":"1990","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcf.2012.06.006_bb0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1183\/09031936.05.00119504","article-title":"Combination aerosol therapy to treat Burkholderia cepacia complex","volume":"26","author":"Middleton","year":"2005","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jcf.2012.06.006_bb0095","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1378\/chest.112.5.1283","article-title":"Airway deposition and clearance and systemic pharmacokinetics of amiloride following aerosolization with an ultrasonic nebulizer to normal airways","volume":"112","author":"Noone","year":"1997","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcf.2012.06.006_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1099-0496(200007)30:1<25::AID-PPUL5>3.0.CO;2-C","article-title":"French multicenter randomized double-blind placebo-controlled trial on nebulized amiloride in cystic fibrosis patients. The Amiloride-AFLM Collaborative Study Group","volume":"30","author":"Pons","year":"2000","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.jcf.2012.06.006_bb0105","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1183\/09031936.93.06091243","article-title":"No added benefit from nebulized amiloride in patients with cystic fibrosis","volume":"6","author":"Graham","year":"1993","journal-title":"Eur Respir J"},{"issue":"9008","key":"10.1016\/j.jcf.2012.06.006_bb0110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(96)90329-3","article-title":"Concentration of inhaled amiloride in cystic fibrosis","volume":"347","author":"Viaca","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcf.2012.06.006_bb0115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ppul.1950170605","article-title":"In vitro suppression of Pseudomonas cepacia after limited exposure to subinhibitory concentrations of amiloride and 5-(N, N-hexamethylene) amiloride","volume":"17","author":"Cohn","year":"1994","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2012.06.006_bb0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000239543","article-title":"Substituted amines synergistic with tobramycin against Burkholderia cepacia in vitro","volume":"43","author":"Cohn","year":"1997","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1016\/j.jcf.2012.06.006_bb0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/AAC.32.3.395","article-title":"In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis","volume":"32","author":"Cohn","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jcf.2012.06.006_bb0130","first-page":"724","article-title":"The effect of sodium on amiloride-tobramycin synergy in Pseudomonas cepacia","volume":"114","author":"Cohn","year":"1989","journal-title":"J Lab Clin Med"},{"issue":"11","key":"10.1016\/j.jcf.2012.06.006_bb0135","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/thx.2003.017210","article-title":"Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis","volume":"59","author":"Jones","year":"2004","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jcf.2012.06.006_bb0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1022037320039","article-title":"Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients","volume":"12","author":"Henry","year":"2003","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jcf.2012.06.006_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcf.2009.11.001","article-title":"Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?","volume":"9","author":"Ball","year":"2010","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199312001270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199312001270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T03:37:07Z","timestamp":1687750627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199312001270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1569199312001270"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2012.06.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}